MBRX

Moleculin Biotech (MBRX) P/E Ratio
P/E Ratio as of Nov 17, 2026: -0.57
Average-0.1455
Median-0.0250
Minimum-0.6600
Maximum-0.0200
-0.57
0.10 (21.28%)past month
The P/E ratio for Moleculin Biotech (MBRX) is -0.57 as of Nov 17, 2026. This represents a increase of 307.14% compared to its 12-month average P/E ratio of -0.14. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Moleculin Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Moleculin Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Moleculin Biotech to industry peers.
Moleculin Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Moleculin Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Moleculin Biotech to industry peers.
Moleculin Biotech (MBRX) P/E Ratio Insights
See Moleculin Biotech’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Moleculin Biotech (MBRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Moleculin Biotech (MBRX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 2, 2026 | $8.32 | -0.02 |
| Oct 1, 2026 | $10.076 | -0.85 |
| Sep 1, 2026 | $13.00 | -0.04 |
| Aug 3, 2026 | $8.50 | -0.02 |
| Jul 1, 2026 | $53.80 | -0.16 |
| Jun 1, 2026 | $52.80 | -0.09 |
| May 1, 2026 | $50.20 | -0.09 |
| Apr 1, 2026 | $44.60 | -0.08 |
| Mar 2, 2026 | $47.60 | -0.06 |
| Feb 2, 2026 | $82.40 | -0.10 |
| Jan 2, 2026 | $72.40 | -0.09 |
Moleculin Biotech (MBRX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.57 | +612.50% |
| 2025 | -0.08 | -66.67% |
| 2024 | -0.24 | -74.74% |
| 2023 | -0.95 | -21.49% |
| 2022 | -1.21 | -60.59% |
| 2021 | -3.07 | — |
FAQs About Moleculin Biotech (MBRX) P/E ratio
The latest P/E ratio of Moleculin Biotech (MBRX) is -0.57, as of Nov 17, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Moleculin Biotech’s last 12-month average P/E ratio is -0.14, compared to its current P/E ratio of -0.57. This reflects a increase of 307.14%.
Moleculin Biotech’s current P/E ratio of -0.57 is higher than its last 12-month average P/E of -0.14. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Moleculin Biotech’s average P/E ratio over the last 3 years is -0.24. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Moleculin Biotech’s average P/E ratio over the last 5 years is -0.77. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Moleculin Biotech (MBRX) P/E Ratio Insights
See Moleculin Biotech’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Moleculin Biotech (MBRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.